Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
Abstract Background A 31-gene expression profile (GEP) test that provides risk classification of cutaneous melanoma (CM) patients has been validated in several retrospective studies. The objective of the reported study was a prospective evaluation of the GEP performance in patients enrolled in two c...
Main Authors: | Eddy C. Hsueh, James R. DeBloom, Jonathan Lee, Jeffrey J. Sussman, Kyle R. Covington, Brooke Middlebrook, Clare Johnson, Robert W. Cook, Craig L. Slingluff, Kelly M. McMasters |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-017-0520-1 |
Similar Items
-
Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
by: Robert W. Cook, et al.
Published: (2018-02-01) -
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
by: Jonathan S. Zager, et al.
Published: (2018-02-01) -
Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
by: Eddy C. Hsueh, et al.
Published: (2017-10-01) -
Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing
by: Natasha M. van Poppelen, et al.
Published: (2021-12-01) -
Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma
by: Jennifer Keller, et al.
Published: (2019-05-01)